Cardiac Excitation and Contraction: Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12

Cardiomyocyte-restricted overexpression of FK506-binding protein 12 transgenic (αMyHC-FKBP12) mice develop spontaneous atrial fibrillation (AF). The aim of the present study is to explore the mechanisms underlying the occurrence of AF in αMyHC-FKBP12 mice. Spontaneous AF was documented by telemetry in vivo and Langendorff-perfused hearts of αMyHC-FKBP12 and littermate control mice in vitro. Atrial conduction velocity was evaluated by optical mapping. The patch-clamp technique was applied to determine the potentially altered electrophysiology in atrial myocytes. Channel protein expression levels were evaluated by Western blot analyses. Spontaneous AF was recorded in four of seven αMyHC-FKBP12 mice but in none of eight nontransgenic (NTG) controls. Atrial conduction velocity was significantly reduced in αMyHC-FKBP12 hearts compared with NTG hearts. Interestingly, the mean action potential duration at 50% but not 90% was significantly prolonged in αMyHC-FKBP12 atrial myocytes compared with their NTG counterparts. Consistent with decreased conduction velocity, average peak Na current (I ) density was dramatically reduced and the I inactivation curve was shifted by approximately +7 mV in αMyHC-FKBP12 atrial myocytes, whereas the activation and recovery curves were unaltered. The Na 1.5 expression level was significantly reduced in αMyHC-FKBP12 atria. Furthermore, we found increases in atrial Ca 1.2 protein levels and peak L-type Ca current density and increased levels of 1,2 2 2,4 3 3,5 2 2 6 3 2 7 3 2 3 1,3

[1]  K. Tsaneva-Atanasova,et al.  FKBP12 Activates the Cardiac Ryanodine Receptor Ca2+-Release Channel and Is Antagonised by FKBP12.6 , 2012, PloS one.

[2]  D. Roden,et al.  Striking In Vivo Phenotype of a Disease-Associated Human SCN5A Mutation Producing Minimal Changes in Vitro , 2011, Circulation.

[3]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[4]  M. Fishbein,et al.  FKBP12 Is a Critical Regulator of the Heart Rhythm and the Cardiac Voltage-Gated Sodium Current in Mice , 2011, Circulation research.

[5]  Ning Wang,et al.  MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation , 2010, Circulation.

[6]  S. Tsang,et al.  Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. , 2010, American journal of physiology. Cell physiology.

[7]  Stefan Wagner,et al.  Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. , 2010, Journal of the American College of Cardiology.

[8]  S. Connolly,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[9]  D. Roden,et al.  Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation , 2008, Circulation.

[10]  A. Wilde,et al.  Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. , 2008, Trends in cardiovascular medicine.

[11]  D. Franco,et al.  Tissue distribution and subcellular localization of the cardiac sodium channel during mouse heart development. , 2008, Cardiovascular research.

[12]  D. Tester,et al.  A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia. , 2007, Cardiovascular research.

[13]  Andrew C. Zygmunt,et al.  Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine , 2007, Circulation.

[14]  T. Olson,et al.  A Common Polymorphism in SCN5A is Associated with Lone Atrial Fibrillation , 2007, Clinical pharmacology and therapeutics.

[15]  P. Carmeliet,et al.  Overlap Syndrome of Cardiac Sodium Channel Disease in Mice Carrying the Equivalent Mutation of Human SCN5A-1795insD , 2006, Circulation.

[16]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[17]  J. D. de Bakker,et al.  Impaired Impulse Propagation in Scn5a-Knockout Mice: Combined Contribution of Excitability, Connexin Expression, and Tissue Architecture in Relation to Aging , 2005, Circulation.

[18]  D. Gros,et al.  Mouse Model of SCN5A-Linked Hereditary Lenègre’s Disease: Age-Related Conduction Slowing and Myocardial Fibrosis , 2005, Circulation.

[19]  Y. Rudy,et al.  Basic mechanisms of cardiac impulse propagation and associated arrhythmias. , 2004, Physiological reviews.

[20]  C. Lau,et al.  Heterogeneity of sodium current in atrial vs epicardial ventricular myocytes of adult guinea pig hearts. , 2002, Journal of molecular and cellular cardiology.

[21]  M. Rosen,et al.  Density and function of inward currents in right atrial cells from chronically fibrillating canine atria. , 2002, Cardiovascular research.

[22]  A. A. Armoundas,et al.  Electrical and structural remodeling of the failing ventricle. , 2001, Pharmacology & therapeutics.

[23]  C. Tracy,et al.  QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. , 1998, Transplantation.

[24]  S. Marx,et al.  Coupled gating between individual skeletal muscle Ca2+ release channels (ryanodine receptors) , 1998, Science.

[25]  M. Matzuk,et al.  Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12 , 1998, Nature.

[26]  P. Baliga,et al.  Bradycardia Associated with Intravenous Administration of Tacrolimus in a Liver Transplant Recipient , 1997, Pharmacotherapy.

[27]  S. Mizuno,et al.  Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. , 1997, Transplantation.

[28]  E. Lakatta,et al.  The immunophilin FK506‐binding protein modulates Ca2+ release channel closure in rat heart. , 1997, The Journal of physiology.

[29]  D. Bers,et al.  Effects of FK-506 on contraction and Ca2+ transients in rat cardiac myocytes. , 1996, Circulation research.

[30]  P. Donahoe,et al.  The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors , 1996, Cell.

[31]  J. Ruskin,et al.  Cardiac sodium channel mutation in atrial fibrillation. , 2008, Heart rhythm.